A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
CROSS COUNTRY HEALTHCARE INC
CCRN
$429M
Mkt Cap
$13.25
+0.00%
CROSS COUNTRY HEALTHCARE INC (CCRN) has a 5-year average return on invested capital (ROIC) of 11.8%. This indicates solid capital allocation.
CROSS COUNTRY HEALTHCARE INC (CCRN) has a market capitalization of $429M. It is classified as a small-cap stock.
CROSS COUNTRY HEALTHCARE INC (CCRN) does not currently pay a regular dividend. However, the company returns capital to shareholders through share buybacks, with a buyback yield of 1.59%.
CROSS COUNTRY HEALTHCARE INC (CCRN) operates in the Services-Help Supply Services industry, within the Industrials sector.
CROSS COUNTRY HEALTHCARE INC (CCRN) reported annual revenue of $1.1 billion in its most recent fiscal year, based on SEC EDGAR filings.
CROSS COUNTRY HEALTHCARE INC (CCRN) has a net profit margin of -9.0%. The company is currently unprofitable.
CROSS COUNTRY HEALTHCARE INC (CCRN) generated $40 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
Overview of Our Company Cross Country Healthcare, Inc. (Nasdaq: CCRN) is a healthcare workforce solutions company delivering an AI-powered digital platform and advisory services, backed by nearly 40 years of healthcare labor expertise, to help health systems optimize and sustain their entire labor ecosystem. Through Intellify®, Cross Country's cloud-based workforce management and vendor management system, health systems gain clear visibility across internal and contingent labor. Intellify® integrates with core hospital systems and brings all service lines, including non-clinical, nursing, allied health, and locums, into one centralized view. Powered by real-time analytics and AI-driven insights, Intellify® helps leaders make smarter workforce decisions, streamline operations, reduce labor costs, improve flexibility, and support high-quality outcomes.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 1.1B | 1.1B | 1.3B | 2.0B | 2.8B | 1.7B |
| Net Income | -95M | -95M | -15M | 73M | 188M | 132M |
| EPS | $-2.93 | $-2.93 | $-0.44 | $2.05 | $4.95 | $3.53 |
| Free Cash Flow | 40M | 40M | 111M | 235M | 125M | -93M |
| ROIC | -30.8% | -25.6% | -3.3% | 15.1% | 36.5% | 36.4% |
| Gross Margin | 20.3% | 20.3% | 20.4% | 22.3% | 22.3% | 22.4% |
| Debt/Equity | 0.01 | 0.01 | 0.01 | 0.01 | 0.35 | 0.68 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -84M | -84M | -17M | 113M | 270M | 139M |
| Operating Margin | -8.0% | -8.0% | -1.3% | 5.6% | 9.6% | 8.3% |
| ROE | -29.4% | -25.6% | -3.3% | 15.8% | 50.5% | 58.8% |
| Shares Outstanding | 32M | 32M | 33M | 35M | 38M | 37M |
| Metric | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 618M | 767M | 834M | 865M | 816M | 822M | 836M | 1.7B | 2.8B | 2.0B | 1.3B | 1.1B | 1.1B |
| Gross Margin | 25.5% | 25.7% | 26.6% | 26.4% | 25.7% | 24.8% | 24.2% | 22.4% | 22.3% | 22.3% | 20.4% | 20.3% | 20.3% |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | 141M | 161M | 180M | 187M | 180M | 182M | 174M | 216M | 324M | 300M | 233M | 201M | 201M |
| EBIT | -10M | 21M | 6.2M | 12M | -13M | -16M | -9.2M | 139M | 270M | 113M | -17M | -84M | -84M |
| Op. Margin | -1.7% | 2.7% | 0.7% | 1.4% | -1.6% | -1.9% | -1.1% | 8.3% | 9.6% | 5.6% | -1.3% | -8.0% | -8.0% |
| Net Income | -32M | 4.4M | 8.0M | 38M | -17M | -58M | -13M | 132M | 188M | 73M | -15M | -95M | -95M |
| Net Margin | -5.1% | 0.6% | 1.0% | 4.3% | -2.1% | -7.0% | -1.5% | 7.9% | 6.7% | 3.6% | -1.1% | -9.0% | -9.0% |
| Non-Recurring | 840K | -910K | 25M | 15M | 25M | 20M | 16M | 4.7M | 7.5M | 3.3M | 4.7M | 75M | 75M |
| Returns on Capital | |||||||||||||
| ROIC | -5.6% | 9.6% | 3.4% | 13.3% | -5.4% | -5.1% | -5.8% | 36.4% | 36.5% | 15.1% | -3.3% | -25.6% | -30.8% |
| ROE | -21.9% | 3.3% | 5.5% | 19.3% | -7.5% | -30.4% | -8.2% | 58.8% | 50.5% | 15.8% | -3.3% | -25.6% | -29.4% |
| ROA | -11.1% | 1.3% | 2.1% | 8.8% | -3.8% | -14.3% | -3.5% | 24.2% | 22.4% | 8.9% | -2.3% | -18.3% | -21.1% |
| Cash Flow | |||||||||||||
| Op. Cash Flow | -4.1M | 18M | 30M | 46M | 21M | 5.5M | 27M | -86M | 134M | 248M | 120M | 48M | 48M |
| Free Cash Flow | -8.6M | 16M | 24M | 40M | 16M | 2.6M | 23M | -93M | 125M | 235M | 111M | 40M | 40M |
| Owner Earnings | -13M | 7.7M | 18M | 31M | 5.6M | -12M | 9.1M | -102M | 114M | 224M | 96M | 24M | 24M |
| CapEx | 4.6M | 2.4M | 6.5M | 5.1M | 4.6M | 2.9M | 4.6M | 7.2M | 8.8M | 14M | 8.7M | 8.2M | 8.2M |
| Maint. CapEx | 7.4M | 8.1M | 9.2M | 10M | 12M | 14M | 13M | 9.9M | 13M | 18M | 18M | 17M | 17M |
| Growth CapEx | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| D&A | 7.4M | 8.1M | 9.2M | 10M | 12M | 14M | 13M | 9.9M | 13M | 18M | 18M | 17M | 17M |
| CapEx/OCF | N/A | 13.0% | 21.6% | 11.2% | 21.9% | 53.0% | 17.0% | N/A | 6.6% | 5.6% | 7.3% | N/A | 16.9% |
| Capital Allocation | |||||||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 5.0M | 0 | 0 | 0 | 35M | 58M | 37M | 6.8M | 6.8M |
| Buyback Yield | N/A | N/A | N/A | N/A | 1.9% | N/A | N/A | N/A | 3.5% | 7.2% | 6.3% | 0.0% | 1.6% |
| Stock-Based Comp | 1.4M | 2.5M | 3.4M | 4.1M | 3.6M | 3.4M | 5.4M | 6.9M | 7.4M | 6.6M | 6.0M | 7.1M | 7.1M |
| Debt Repayment | 0 | 0 | 31M | 1.5M | 16M | 84M | 438M | 488M | 1.6B | 798M | 18M | 1.4M | 1.4M |
| Balance Sheet | |||||||||||||
| Net Debt | 69M | 94M | 66M | 74M | 67M | 165M | 130M | 200M | 156M | -12M | -78M | -106M | -106M |
| Cash & Equiv. | 5.0M | 2.5M | 21M | 26M | 16M | 1.0M | 1.6M | 1.0M | 3.6M | 17M | 82M | 109M | 109M |
| Long-Term Debt | 70M | 96M | 85M | 92M | 78M | 71M | 56M | 182M | 151M | 0 | 0 | N/A | 2.3M |
| Debt/Equity | 0.57 | 0.68 | 0.58 | 0.42 | 0.38 | 1.02 | 0.85 | 0.68 | 0.35 | 0.01 | 0.01 | 0.01 | 0.01 |
| Interest Coverage | -2.5 | 3.0 | 1.0 | 2.8 | -2.3 | -3.0 | -3.2 | 20.3 | 18.8 | 13.9 | -7.7 | -38.1 | -38.1 |
| Equity | 130M | 141M | 151M | 237M | 218M | 163M | 154M | 294M | 451M | 468M | 419M | 323M | 323M |
| Total Assets | 325M | 366M | 388M | 468M | 427M | 382M | 357M | 733M | 950M | 681M | 589M | 449M | 449M |
| Total Liabilities | 195M | 224M | 237M | 230M | 209M | 219M | 202M | 435M | 498M | 213M | 170M | 126M | 126M |
| Intangibles | 34M | 83M | 72M | 88M | 76M | 45M | 35M | 48M | 45M | 54M | 42M | 28M | 28M |
| Retained Earnings | -116M | -112M | -104M | -67M | -84M | -142M | -155M | -23M | 160M | 233M | 218M | 123M | 123M |
| Working Capital | 64M | 73M | 109M | 114M | 110M | 98M | 90M | 309M | 398M | 261M | 215M | 216M | 216M |
| Current Assets | 131M | 159M | 206M | 209M | 195M | 183M | 183M | 508M | 677M | 417M | 335M | 294M | 294M |
| Current Liabilities | 67M | 86M | 97M | 95M | 85M | 85M | 93M | 200M | 279M | 156M | 120M | 78M | 78M |
| Per Share Data | |||||||||||||
| EPS | -1.02 | 0.14 | 0.15 | 1.01 | -0.48 | -1.61 | -0.36 | 3.53 | 4.95 | 2.05 | -0.44 | -2.93 | -2.93 |
| Owner EPS | -0.41 | 0.24 | 0.33 | 0.84 | 0.16 | -0.33 | 0.25 | -2.74 | 3.00 | 6.31 | 2.90 | 0.75 | 0.75 |
| Book Value | 4.17 | 4.46 | 2.85 | 6.38 | 6.16 | 4.54 | 4.29 | 7.87 | 11.86 | 13.20 | 12.66 | 9.97 | 9.97 |
| Cash Flow/Share | -0.13 | 0.58 | 0.57 | 1.23 | 0.59 | 0.15 | 0.76 | -2.29 | 3.52 | 7.01 | 3.63 | 1.49 | -2.41 |
| Dividends/Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 31.2M | 31.6M | 53.1M | 37.1M | 35.3M | 35.8M | 36.0M | 37.4M | 38.1M | 35.4M | 33.1M | 32.4M | 32.4M |
| Valuation | |||||||||||||
| P/E Ratio | N/A | 120.6 | 101.8 | 12.8 | N/A | N/A | N/A | 8.0 | 5.5 | 11.1 | N/A | N/A | -4.5 |
| P/FCF | N/A | 33.6 | 34.3 | 11.9 | 16.0 | 159.1 | 14.5 | N/A | 8.2 | 3.4 | 5.3 | N/A | 10.7 |
| EV/EBIT | N/A | 26.2 | 141.9 | 47.1 | N/A | N/A | N/A | 8.9 | N/A | N/A | N/A | N/A | N/A |
| Price/Book | 3.2 | 3.8 | 5.4 | 2.0 | 1.2 | 2.5 | 2.1 | 3.5 | 2.2 | 1.7 | 1.4 | N/A | 1.3 |
| Price/Sales | 0.4 | 0.5 | 0.8 | 0.6 | 0.5 | 0.4 | 0.3 | 0.4 | 0.3 | 0.4 | 0.4 | N/A | 0.4 |
| FCF Yield | -2.1% | 3.0% | 2.9% | 8.4% | 6.3% | 0.6% | 6.9% | -8.8% | 12.4% | 29.2% | 18.7% | N/A | 9.3% |
| Market Cap | 416M | 533M | 811M | 479M | 262M | 414M | 328M | 1.1B | 1.0B | 803M | 595M | 0 | 429M |
| Avg. Price | 8.54 | 13.05 | 13.23 | 13.36 | 10.78 | 9.33 | 7.53 | 17.05 | 24.77 | 24.49 | 15.97 | 0.00 | 13.25 |
| Year-End Price | 13.34 | 16.89 | 15.27 | 12.91 | 7.43 | 11.55 | 9.12 | 28.24 | 26.98 | 22.67 | 18.00 | 0.00 | 13.25 |
CROSS COUNTRY HEALTHCARE INC passes 3 of 9 quality checks, indicating weak fundamentals.
On a free-cash-flow basis, the stock trades at 9.5x vs a median of 11.9x. The company's 5-year average ROIC is 11.8% with a gross margin of 21.5%. Total shareholder yield (buybacks) is 1.6%. At current prices, the estimated annualized return to fair value is +60.1%.
CROSS COUNTRY HEALTHCARE INC (CCRN) has a debt-to-equity ratio of 0.01. This indicates a conservatively financed balance sheet.
CROSS COUNTRY HEALTHCARE INC (CCRN) reported earnings per share (EPS) of $-2.93 in its most recent fiscal year.
CROSS COUNTRY HEALTHCARE INC (CCRN) has a return on equity (ROE) of -25.6%. A negative ROE may indicate losses or negative equity.
CROSS COUNTRY HEALTHCARE INC (CCRN) has a 5-year average gross margin of 21.5%. This lower margin is typical of capital-intensive or commodity businesses.
The Ledger Terminal provides 17 years of financial data for CROSS COUNTRY HEALTHCARE INC (CCRN), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
CROSS COUNTRY HEALTHCARE INC (CCRN) has a book value per share of $9.97, based on its most recent annual SEC filing.